Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial
Trials, Volume 15, Issue 496, 2014, Pages 496-496.
South AfricaHIV preventionMicrobicideTenofovir gelHealth systems strengtheningMore(1+)
The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 trial demonstrated a 39% reduction in HIV infection, with a 54% HIV reduction in women who used tenofovir gel consistently. A confirmatory trial is expected to report results in early 2015. In the interim, we have a unique window of opportunity to prepare for and ...More
Full Text (Upload PDF)